SURG

Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM Total revenue 9.6 M10.58 M11.52 M18.68 M16.19 M 56.96 M Gross profit -11.23 M-2.94 M-2.65 M-2.6 M-2.4 M -10.59 M Operating expenses 7.15 M4.64 M4.16 M4.35 M6.92 M 20.07 M Selling/general/admin expenses 7.15 M4.64 M4.16 M4.35 M6.92 M 20.07 M Research & development ————— — Operating income -18.38 M-7.58 M-6.81 M-6.95 M-12.8 M -34.14 M Non-Operating Income, Total -1.71 M-55.39 K-272.3 K-539.16 K-1.07 M -1.93 M Interest expense, net of interest capitalized 554.2 K238.87 K212.42 K424.67 K1.25 M 2.12 M Non-Operating Income, excl. Interest Expenses -1.71 M-301.4 K-484.36 K-964.18 K-2.31 M -4.06 M Unusual income/expense -2397 140-3553550 7 140 Pretax income -20.09 M-7.64 M-7.08 M-7.49 M-13.86 M -36.07 M Equity in earnings ————— — Taxes -100 K0001.22 M 1.22 M Non-controlling/minority interest -172.56 K-209-209-227-193 -838 After tax other income/expense ————— — Net income before discontinued operations -19.81 M-7.64 M-7.08 M-7.49 M-13.86 M -36.07 M Discontinued operations —0——— — Net income -19.81 M-7.64 M-7.08 M-7.49 M-13.86 M -36.07 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -19.81 M-7.64 M-7.08 M-7.49 M-13.86 M -36.07 M Basic earnings per share (Basic EPS) -1.07-0.38-0.36-0.38-0.68 -1.8 Diluted earnings per share (Diluted EPS) -1.07-0.38-0.36-0.38-0.68 -1.8 Average basic shares outstanding 19.12 M20.07 M19.89 M19.84 M20.09 M 79.88 M Diluted shares outstanding 19.12 M20.07 M19.89 M19.84 M20.09 M 79.88 M EBITDA -17.67 M-7.49 M-6.74 M-6.92 M-12.77 M -33.93 M EBIT -18.38 M-7.58 M-6.81 M-6.95 M-12.8 M -34.14 M Cost of revenue 20.83 M13.52 M14.17 M21.28 M18.58 M 67.55 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 709.62 K86.12 K66.36 K26.84 K26.84 K 206.16 K